The EU Mancozeb Task Force, comprising UPL and Indofil Industries has applied for renewal of the approval of the fungicide, mancozeb in Great Britain.
It is working to submit a full dossier for renewal later this year. This application will then be evaluated in due course, according to UPL.
Since the entry into force of the EC non-renewal regulation for mancozeb was after December 31, 2020, the end of the Brexit transition period, mancozeb remains approved in Great Britain. Moreover, in line with the general transitional provisions, the approval period was extended for three years until January 31, 2024.
UPL country manager, Vaughn Stansfield said: “Although Brexit might have shielded us from the near immediate withdrawals that the rest of Europe will suffer, we realise that we will have to continue fighting for this key active to remain in Great Britain, and are working hard to do everything we can within the process to support its application for renewal.”
In most EU countries the maximum grace periods of six months for the sale and distribution of mancozeb products (until the July 4, 2021) and a subsequent additional six months for the use of stocked mancozeb products (until January 4, 2022) are being granted, according to the EU Mancozeb Task Force.